香港股市 已收市

Boston Scientific Corporation (BSX)

NYSE - Nasdaq 即時價格。貨幣為 USD。
加入追蹤清單
39.76-0.89 (-2.19%)
收市價: 04:00PM EDT
39.29 -0.47 (-1.18%)
收市後: 05:47PM EDT
全螢幕
交易股價資料並非來自所有市場
前收市價40.65
開市40.27
買盤38.83 x 3000
賣出價39.34 x 2200
今日波幅39.60 - 40.43
52 週波幅34.98 - 47.50
成交量8,581,963
平均成交量6,656,159
市值56.921B
Beta 值 (5 年,每月)0.85
市盈率 (最近 12 個月)65.18
每股盈利 (最近 12 個月)0.61
業績公佈日2022年10月25日 - 2022年10月31日
遠期股息及收益率無 (無)
除息日
1 年預測目標價48.49
  • Insider Monkey

    10 Best Healthcare Stocks to Buy According to Billionaire Larry Robbins

    This article discusses the top 10 healthcare stock picks of billionaire Larry Robbins’ hedge fund Glenview Capital Management. To learn about the fund’s top five stock picks from the healthcare and pharmaceutical industry, you can skip ahead and check out 5 Best Healthcare Stocks to Buy According to Billionaire Larry Robbins. Larry Robbins is the […]

  • Insider Monkey

    Billionaire Izzy Englander’s Latest Portfolio: Top 10 Stock Picks

    The top ten stocks selected by Billionaire Izzy Englander’s Millennium Management at the end of the second quarter are covered in this article. If you’re just interested in learning about this fund’s top five stock recommendations, please visit Billionaire Izzy Englander’s Latest Portfolio: Top 5 Stock Picks. Israel “Izzy” Englander, who is based in New […]

  • Benzinga

    Boston Scientific Adds 'Novel' Technology Via This Acquisition For Interventional Oncology

    Boston Scientific Corporation (NYSE: BSX) has acquired privately-held Obsidio Inc that developed the Gel Embolic Material (GEM) technology to embolize blood vessels in the peripheral vasculature. Deal terms were not disclosed. Embolization is a minimally invasive procedure intended to obstruct or reduce blood flow to an abnormality or tumor to stop hemorrhaging, reduce the size of malignant and benign tumors, and stabilize venous and arterial malformations. Recently cleared by the FDA, the GEM t